Publications by authors named "Chuan-Rui Xu"

Claim this Profile
A
A Difluorinated Derivative of ARC-111 Suppresses Intrahepatic Cholangiocarcinoma Growth via Targeting Topoisomerase I.
Yin-Peng Bai, Mi Zhang, Jian-Hua Liu, Gui-Sha Chen, Cheng-Jie Yang, Chuan-Rui Xu

ACS Pharmacol Transl Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I.
Mi Zhang, Li-Zu Zhu, Cheng-Jie Yang, Jia-Xuan Yan, Zhi-Ping Wang, Chuan-Rui Xu

Bioorg Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects and mechanism of a novel camptothecin derivative YCJ100.
Mi Zhang, Wen Fu, Li-Zu Zhu, Xiao-Fei Liu, Lei Li, Chuan-Rui Xu

Life Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma.
Yin-Peng Bai, Cheng-Jie Yang, Nan Deng, Mi Zhang, Zhi-Jun Zhang, Chuan-Rui Xu

Biochem Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of Aza-boeravinone derivatives as potential novel topoisomerase I inhibitors.
Yong Zhou, Yin-Peng Bai, Mi Zhang, Jian-Mei Gao, Cheng-Jie Yang, Chuan-Rui Xu

Bioorg Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel 20(S)-α-aminophosphonate derivatives of camptothecin as potent antitumor agents.
Yu-Yuan Chen, Yin-Peng Bai, Bin Li, Xiao-Bo Zhao, Cheng-Jie Yang, Chuan-Rui Xu

Bioorg Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: The Role of CARD9 in Metabolic Diseases.
Cheng Tian, Ya-Li Tuo, Yi Lu, Chuan-Rui Xu, Ming Xiang

Curr Med Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of CARD9 in Metabolic Diseases.
Cheng Tian, Ya-Li Tuo, Yi Lu, Chuan-Rui Xu, Ming Xiang

Curr Med Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma.
Jun Guo, Wen Fu, Ming Xiang, Yu Zhang, Ke Zhou, Chuan-Rui Xu

Curr Med Sci· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
Hui-Ying Xue, Yong Liu, Jia-Zhi Liao, Ju-Sheng Lin, Bin Li, Chuan-Rui Xu

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Hong-Bo Luo, Bin Li, Wei-Gang Yuan, Chuan-Rui Xu

J Huazhong Univ Sci Technolog Med Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
Xing-Xing He, Shu-Zhen Kuang, Jia-Zhi Liao, Chuan-Rui Xu, Ying Chang

Mol Biosyst· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
Xing-Xing He, An-Yuan Guo, Chuan-Rui Xu, Ying Chang, Guang-Ya Xiang

Oncol Rep· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
Dong Xu, Xing-Xing He, Ying Chang, Shu-Zhen Sun, Chuan-Rui Xu

Hepatogastroenterology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Chuan-Rui Xu, Susie Lee, Coral Ho, Prashant Bommi, Shi-Ang Huang

Mol Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chloromycetin resistance of clinically isolated E coli is conversed by using EGS technique to repress the chloromycetin acetyl transferase.
Mei-Ying Gao, Chuan-Rui Xu, Ru Chen, Shou-Gui Liu, Jiang-Nan Feng

World J Gastroenterol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis